The Diagnostic and Prognostic Roles of Combined Expression of Novel Biomarkers in Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Carcinoma (LUSC); An Immunohistochemical Study

• Autori principali: Mohamed Alabiad (Autore), Ola Harb (Autore), Mohamed Abozaid (Autore), Ahmed Embaby (Autore), Doaa Mandour (Autore), Rehab Hemeda (Autore), Amany Shalaby (Autore)
• Natura: Libro
• Pubblicazione: Iranian Society of Pathology, 2020-12-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Background and Objective: Diagnosis and discrimination of lung adenocarcinoma (LUAD) from lung squamous cell carcinoma (LUSC) is critical to select the appropriate treatment regimen as recently targeted therapies require accurate subtyping of NSCLCs. There are currently several biomarkers that could...